Estrace and breast microcalcification Patient Reports February 12, 2012

Estrace Side Effects Report #4555959-9
Estrace side effect was reported by a Consumer or non-health professional from on Aug 16, 2004. Female patient, 59 years of age, was treated with Estrace. After drug was administered, patient experienced the following side effects: breast cancer , breast cancer female, breast fibrosis, breast microcalcification, fibrocystic breast disease, oestrogen receptor assay positive, progesterone receptor assay positive. Estrace dosage: DOSE: 2MG DAILY DAYS 1-25. During the same period patient was treated with MICRONOR, PREMARIN, PREMPRO, PROVERA. Patient recovered.

Estrace Side Effects Report #4554546-6
Estrace side effect was reported by a Consumer or non-health professional from on Mar 09, 2004. Female patient, 57 years of age, was diagnosed with asthma  and was treated with Estrace. After drug was administered, patient experienced the following side effects: breast cancer , breast cancer stage iii, breast microcalcification, oestrogen receptor assay positive. Estrace dosage: unknown. During the same period patient was treated with PROVERA, ESTRATEST H, ALBUTEROL, ADVAIR DISKUS. Patient recovered.

Estrace Side Effects Report #4686615-4
Estrace side effect was reported by a Consumer or non-health professional from on Aug 05, 2004. Female patient, 56 years of age, was treated with Estrace. After drug was administered, patient experienced the following side effects: breast cancer , breast microcalcification, oestrogen receptor assay positive, progesterone receptor assay positive. Estrace dosage: unknown. During the same period patient was treated with PREMARIN, PROVERA, EVISTA. Patient recovered.

Estrace Side Effects Report #4896895-8
Estrace side effect was reported by a Consumer or non-health professional from UNITED STATES on July 20, 2004. Female patient, 54 years of age, was treated with Estrace. After drug was administered, patient experienced the following side effects: breast cancer , breast cancer in situ, breast microcalcification, oestrogen receptor assay positive, progesterone receptor assay positive. Estrace dosage: unknown. During the same period patient was treated with PREMPRO, PREMARIN, MEDROXYPROGESTERONE ACETATE, CLIMARA, PROVERA, ESTROGEN, ACTIVELLA. Patient recovered.